Home › Research › Topics › neuroprotective-agents
neuroprotective-agents
2 studies tagged neuroprotective-agents, dated 2001-09-01 to 2021-02-08. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Repurposing of Omarigliptin as a Neuroprotective Agent Based on Docking with A2A Adenosine and AChE Receptors, Brain GLP-1 Response and Its Brain/Plasma Concentration Ratio after 28 Days Multiple Doses in Rats Using LC-MS/MS 2021-02-08
- The neuroprotective agent memantine induces brain-derived neurotrophic factor and trkB receptor expression in rat brain 2001-09-01
Studies
2 studies carry this tag.
Date range
2001 to 2021
Top journals
- Molecular and cellular neurosciences 1
- Molecules (Basel, Switzerland) 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
The first finding is the positive results of the docking study with the crystal structures of A 2A adenosine (A2AAR) and acetylcholine esterase (AChE) receptors.
-
Memantine is a medium-affinity uncompetitive N-methyl-d-aspartate receptor antagonist and has been clinically used as a neuroprotective agent to treat Alzheimer's and Parkinson's diseases.